Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around ...

As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a ...

Merck's India sites, which together employ around 1,800 people, focus on multiple therapy areas including oncology, diabetes, vaccines and animal health, as well as technology-related centers.

Merck & Co Inc (NYSE:MRK) is making significant progress in its pipeline, with 20 potential new growth drivers, many with blockbuster potential. The Animal Health business delivered strong ...

Merck shares have been under pressure amid ... The company also operates a major animal-health segment, while engaging in biotechnology development beyond traditional pharmaceuticals.

Marie Bucko joined Merck Animal Health as executive director of global public policy and stakeholder engagement. The Food and ...

The global veterinary dermatology market, valued at US$18.59 billion in 2024, is forecasted to grow at a robust CAGR of 8.5%, ...

Merck (MRK) stock was mangled today after the ... successful launch of WINREVAIR and strong performance of our Animal Health business.” Is MRK Stock a Buy, Sell, or Hold? Turning to Wall Street, ...

It's been a rough start to 2025 for Merck (NYSE: MRK ... The company also operates a major animal-health segment, while engaging in biotechnology development beyond traditional pharmaceuticals.

However, Merck’s (NYSE:MRK) animal health business exceeded forecasts, adding ~$1.4B to the topline with 9% Y/Y growth. Adjusted gross margin was 80.8% for the fourth quarter, compared with 77.2 ...